Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OraSure TechnologiesFRA:EP3 -0.58%56 3-1 Month Momentum % is 42.31% as of Aug. 11, 2026. GuruFocus rates FRA:EP3 with a GF Score™ of 56/100 and a GF Value™ of €1.72 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 846 Medical Devices & Instruments companies, OraSure Technologies ranks better than 96.81% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-11), OraSure Technologies's 3-1 Month Momentum % is 42.31%.
The industry rank for OraSure Technologies's 3-1 Month Momentum % or its related term are showing as below:
FRA:EP3's 3-1 Month Momentum % is ranked better than 96.81% of 846
companies
in the Medical Devices & Instruments industry
Industry Median: -7.435
vs FRA:EP3: 42.31
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
OraSure Technologies 3-1 Month Momentum % Related Terms
FRA:EP3 vs SMTI, UTMD, EMBC: 3-1 Month Momentum % Comparison
For the Medical Instruments & Supplies subindustry, OraSure Technologies's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OraSure Technologies 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, OraSure Technologies's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where OraSure Technologies's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OraSure Technologies (FRA:EP3) has a 3-1 Month Momentum % of 42.31% as of Aug. 11, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on OraSure Technologies and its competitors. According to the industry distribution chart, OraSure Technologies ranks #27 out of 846 companies in the Medical Devices & Instruments industry, placing it in the top 3.2%.
Is OraSure Technologies' 3-1 Month Momentum % too high?
OraSure Technologies' current 3-1 Month Momentum % is 42.31%. Based on the distribution chart, OraSure Technologies ranks #27 out of 846 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, OraSure Technologies has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OraSure Technologies' 3-1 Month Momentum % compare to SMTI and UTMD?
According to the Medical Devices & Instruments industry distribution chart, OraSure Technologies ranks #27 out of 846 companies for 3-1 Month Momentum %. This places OraSure Technologies in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on OraSure Technologies and its competitors. OraSure Technologies's current 3-1 Month Momentum % is 42.31%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OraSure Technologies stock overvalued right now?
Based on GuruFocus' analysis, OraSure Technologies (FRA:EP3) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.72, compared to a current price of €3.42 — trading 98.8% above its estimated fair value. The current 3-1 Month Momentum % is 42.31%. OraSure Technologies' overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For OraSure Technologies (FRA:EP3), the current 3-1 Month Momentum % is 42.31% as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OraSure Technologies (FRA:EP3) Overvalued in 2026?
Based on GuruFocus' analysis, OraSure Technologies stock appears to be overvalued.
The current stock price of €3.42 is trading 98.8% above its estimated GF Value™ of €1.72.
GuruFocus considers OraSure Technologies to be Significantly Overvalued.
Key valuation signals for FRA:EP3:
3-1 Month Momentum %: 42.31%
GF Value™: €1.72 vs. price of €3.42 (98.8% above fair value)
No single metric tells the full story. See the FRA:EP3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.
56GF Score
Get the complete analysis for FRA:EP3
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:EP3 has been successfully added to your 
